Schiff Bases of Pioglitazone Provide Better Antidiabetic and Potent Antioxidant Effect in a StreptozotocināNicotinamide-Induced Diabetic Rodent Model
Sign Up to like & getrecommendations! Published in 2021 at "ACS Omega"
DOI: 10.1021/acsomega.0c06064
Abstract: Pioglitazone is a Food and Drug Administration-approved thiazolidinedione (TZD) derivative and peroxisome proliferator-activated receptor gamma (PPARĪ³) agonist and used for the treatment of diabetes mellitus (DM). However, this drug is still associated with many adverse… read more here.
Keywords: bases pioglitazone; schiff bases; pioglitazone; streptozotocin nicotinamide ... See more keywords